Document is current
Any future updates will be listed below
-
Authors
Zeng, Chang
Song, Xiao
Zhang, Zhou http://orcid.org/0000-0002-9639-052X
Cai, Qinyun
Cai, Jiajun
Horbinski, Craig
Hu, Bo
Cheng, Shi-Yuan
Zhang, Wei
-
Funding
Funding for this research was provided by:
National Institutes of Health (CA209345, NS115403, CA221747)
National Cancer Institute (P50CA221747)
- License Information
-
More Information
Article History
Received: 9 May 2023
Accepted: 9 July 2023
First Online: 14 August 2023
Declarations
:
: This study was performed under a protocol that was approved by the Institutional Review Board (IRB) of Northwestern University Feinberg School of Medicine.
: WZ was an advisor and shareholder of Epican Technology, Ltd., which held a license of the 5hmC-Seal technology from the University of Chicago for clinical applications. The other authors declare that they have no competing interests.
